Information on new approvals and medication safety rheumatologists need to know
Search results for: infliximab
South Korea Okays First Officially Approved Monoclonal Antibody for RA
11 Products Looking for U.S. Marketing Nod
EULAR 2012: Rewards in Risk Factor Research
Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
EULAR 2012: Remission the New Normal for Rheumatoid Arthritis
Advances in the rheumatology clinic are promising, two experts say.
Coding Corner Question: August Coding Challenge
A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.
Coding Corner Answer: August Coding Challenge
A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.
California Rheumatologists Explore Managed Care, Treatment Options
Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances
Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.
Ethics Forum: The Ethical Pitfalls of Clinical Trials
Your patient is deciding whether to enroll in a clinical trial at your institution and wants your advice about whether to participate.
A Short History of Rheumatoid Arthritis Therapeutics
Or, why I chose to become a rheumatologist
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 41
- Next Page »